a public good project by the
Synthesis
Company
of California

© 2026

Andrew H. Baker | doi.page

0 works0 citations0 h-index

Andrew H. Baker

Maastricht University Medical Centre(NL)Maastricht University(NL)University of Edinburgh(GB)

Publications by Year

Research Areas

Virus-based gene therapy research, RNA Interference and Gene Delivery, Viral Infectious Diseases and Gene Expression in Insects, MicroRNA in disease regulation, Cancer-related molecular mechanisms research

Most-Cited Works

→ Metalloproteinase inhibitors: biological actions and therapeutic opportunities(2002)1,164 cited
→ Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure(1999)797 cited
→ A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2(2003)649 cited
→ Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer(2008)645 cited
→ IL-33 reduces the development of atherosclerosis(2008)633 cited
→ Endothelial to Mesenchymal Transition in Cardiovascular Disease(2019)583 cited

→ Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB(1998)

510 cited

→ Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.(1998)463 cited

→ Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension(2010)403 cited

→ Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia(2011)396 cited